Treatment of visceral leishmaniasis
Wali, J.P.; Sharma, S.K.; Guleria, J.S.
Journal of the Association of Physicians of India 32(9): 813-814
1984
ISSN/ISBN: 0004-5772 PMID: 6096351 Document Number: 223526
Document emailed within 1 workday
Related Documents
Ashford, D.A.; Badaro, R.; Eulalio, C.; Freire, M.; Miranda, C.; Zalis, M.G.; David, J.R. 1993: Studies on the control of visceral leishmaniasis: validation of the Falcon assay screening test--enzyme-linked immunosorbent assay (FAST-ELISA) for field diagnosis of canine visceral leishmaniasis American Journal of Tropical Medicine and Hygiene 48(1): 1-8Gelanew, T.; Hurissa, Z.; Diro, E.; Kassahun, A.; Kuhls, K.; Schönian, G.; Hailu, A. 2011: Disseminated cutaneous leishmaniasis resembling post-kala-azar dermal leishmaniasis caused by Leishmania donovani in three patients co-infected with visceral leishmaniasis and human immunodeficiency virus/acquired immunodeficiency syndrome in Ethiopia American Journal of Tropical Medicine and Hygiene 84(6): 906-912
Peterslund, N.A.; Pallesen, G.; Bertel, L. 1982: Visceral leishmaniasis (kala-azar). Report of a case of infantile Mediterranean leishmaniasis Ugeskrift for Laeger 144(40): 2948-2949
Pourahmad, M.; Hooshmand, F.; Rahiminejad, M. 2009: Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS) International Journal of Dermatology 48(1): 59-61
Addadi, K.; Dedet, J.P. 1976: Epidemiology of leishmaniasis in Algeria. 6. Survey of clinical cases of infantile visceral leishmaniasis from 1965 to 1974 Bulletin de la Societe de Pathologie Exotique et de Ses Filiales 69(1): 68-75
Furtado Vieira, J.B.tista.; Evelim Coelho, G. 1998: Visceral leishmaniasis epidemiological and control aspects Leishmaniose visceral ou calazar aspectos epidemiologicos e de controle Revista da Sociedade Brasileira de Medicina Tropical 31: 85-92 (Suplemento 2
Laroche, R.; Sirol, J.; Poli, L. 1978: Treatment of visceral leishmaniasis or kala-azar Medecine Tropicale: Revue du Corps de Sante Colonial 38(4): 401-404
Rosenthal, E.; Marty, P. 2003: Recent understanding in the treatment of visceral leishmaniasis Journal of Postgraduate Medicine 49(1): 61-68
Fusai, T.; Durand, R.; Boulard, Y.; Paul, M.; Bories, C.; Rivollet, D.; Houin, R.; Deniau, M. 1995: Importance of drug carriers in the treatment of visceral leishmaniasis Medecine Tropicale: Revue du Corps de Sante Colonial 55(1): 73-78
Giri, O.P. 1994: Treatment of visceral Leishmaniasis unresponsive to pentamidine with amphotericin B Journal of the Association of Physicians of India 42(9): 688-689
Das, V.N.R.; Ranjan, A.; Bimal, S.; Siddique, N.A.; Pandey, K.; Kumar, N.; Verma, N.; Singh, V.P.; Sinha, P.K.; Bhattacharya, S.K. 2005: Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar National Medical Journal of India 18(3): 131-133
Tavil, B.ül.; Seçmeer, G.ül.; Ozen, H.; Cengiz, A.B.ül.; Unal, S.; Gürgey, A. 2008: Foamy histiocytes in a patient with visceral leishmaniasis after treatment with liposomal amphotericin B Turkish Journal of Pediatrics 50(1): 67-69
Sundar, S.; Mehta, H.; Suresh, A.V.; Singh, S.P.; Rai, M.; Murray, H.W. 2004: Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 38(3): 377-383
Murray, H.W. 2000: Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 4(3): 158-177
Jha, T.K.; Sundar, S.; Thakur, C.P.; Felton, J.Mark.; Sabin, A.J.; Horton, J. 2005: A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in India American Journal of Tropical Medicine and Hygiene 73(6): 1005-1011
Sinha, P.K.; Bimal, S.; Singh, S.K.; Pandey, K.; Gangopadhyay, D.N.; Bhattacharya, S.K. 2006: Pre- and post-treatment evaluation of immunological features in Indian visceral leishmaniasis (VL) patients with HIV co-infection Indian Journal of Medical Research 123(3): 197-202
Ter Horst, R.; Collin, S.M.; Ritmeijer, K.; Bogale, A.; Davidson, R.N. 2008: Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 46(11): 1702-1709
Olliaro, P.L.; Guerin, P.J.; Gerstl, S.; Haaskjold, A.Aga.; Rottingen, J-Arne.; Sundar, S. 2005: Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004 Lancet. Infectious diseases 5(12): 763-774
Nandy, A.; Addy, M.; Maji, A.K.; Guha, S.K. 2004: Impact of a co-factor on the dynamics of Leishmania donovani infection: does HIV infection encourage the recurrence of visceral leishmaniasis following post-kala-azar dermal leishmaniasis? Annals of Tropical Medicine and Parasitology 98(6): 651-654
Singh, G.P.; Saxena, R.K.; Priyadarshy, V. 2010: Amphotericin B--fat emulsion in treatment of visceral leishmaniasis--a cost effective substitute for liposomal amphotericin B Journal of the Indian Medical Association 108(1): 27-28